VRCHOVECKÁ, Kateřina, Jan KUTA, Martin UHER, Jan PŘIBYL and Monika PÁVKOVÁ GOLDBERGOVÁ. Effect of titanium nanostructured surface on fibroblast behavior. Journal of Biomedical Materials Research Part A. HOBOKEN: WILEY111, 2023, vol. 111, No 9, p. 1333-1343. ISSN 1549-3296. Available from: https://dx.doi.org/10.1002/jbm.a.37531.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effect of titanium nanostructured surface on fibroblast behavior
Authors VRCHOVECKÁ, Kateřina (203 Czech Republic, belonging to the institution), Jan KUTA (203 Czech Republic, belonging to the institution), Martin UHER (203 Czech Republic, belonging to the institution), Jan PŘIBYL (203 Czech Republic, guarantor, belonging to the institution) and Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution).
Edition Journal of Biomedical Materials Research Part A, HOBOKEN, WILEY111, 2023, 1549-3296.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 21002 Nano-processes ;
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.900 in 2022
RIV identification code RIV/00216224:14110/23:00130787
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/jbm.a.37531
UT WoS 000958302100001
Keywords in English cell morphology; cell viability; fibroblast; ion release; titanium nanotubes
Tags 14110518, CF CRYO, CF NANO, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 6/4/2024 14:36.
Abstract
As the consumption of implants increases, so do the requirements for individual types of implants, for example, improved biocompatibility or longevity. Therefore, the nano-modification of the titanium surface is often chosen. The aim was to characterize the modified surface with a focus on medical applications. The titanium surface was modified by the anodic oxidation method to form nanotubes. Subsequently, the material was characterized and analyzed for medical applications—surface morphology, surface wettability, chemical composition, and release of ions into biological fluids. A human gingival fibroblasts (HGFb) cell line was used in the viability study. A homogeneous layer of nanotubes of defined dimensions was formed on the titanium surface, ensuring the material's biocompatibility—the preparation conditions influence the resulting properties of the nanostructured surface. Nanostructured titanium exhibited more suitable characteristics (e.g., wettability, roughness, ion release) for biological applications than compared to pure titanium. It was possible to understand the behavior of the modified layer on the titanium surface and its effect on cell behavior. Another contribution of this work is the combination of material characterization (ion release) with the study of cytocompatibility (direct contact of cells with metals).
Links
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
EF18_046/0015974, research and development projectName: Modernizace České infrastruktury pro integrativní strukturní biologii
GA20-11321S, research and development projectName: Vliv mikrostruktury a povrchových úprav na absorpci vodíku v bio-kompatibilních slitinách
Investor: Czech Science Foundation
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
LM2023042, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii
Investor: Ministry of Education, Youth and Sports of the CR, CIISB - Czech Infrastructure for Integrative Structural Biology
MUNI/A/1370/2022, interní kód MUName: Patofyziologie vybraných komplexních nemocí od molekulární do systémovou úroveň
Investor: Masaryk University, Pathophysiology of selected complex diseases from molecular to systemic level
NU20-08-00149, research and development projectName: Multicentrické hodnocení hypersenzitivní reakce u pacientů indikovaných k totální náhradě kloubu včetně hodnocení důvodů reimplanace
Investor: Ministry of Health of the CR, Subprogram 1 - standard
90121, large research infrastructuresName: RECETOX RI
90242, large research infrastructuresName: CIISB III
PrintDisplayed: 20/7/2024 02:30